Richard D Leslie Selected Research

Insulin Resistance

10/2022

C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard D Leslie Research Topics

Disease

5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2022 - 06/2013
4	Type 2 Diabetes Mellitus (MODY) 10/2022 - 01/2018
3	Latent Autoimmune Diabetes in Adults 01/2018 - 01/2018
2	Disease Progression 10/2022 - 10/2021
1	Diabetes Complications 10/2022
1	Insulin Resistance 10/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2019

Drug/Important Bio-Agent (IBA)

5	Insulin (Novolin)FDA Link 10/2022 - 06/2013
2	AutoantibodiesIBA 01/2019 - 01/2018
2	dulaglutideIBA 01/2018 - 01/2018
1	C-PeptideIBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	AntigensIBA 10/2021
1	heat shock protein 60 peptide 277IBA 10/2021
1	MitogensIBA 10/2021
1	ChemokinesIBA 10/2021
1	Chemokine CCL5IBA 10/2021
1	AntibodiesIBA 01/2018
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2018

Therapy/Procedure

1	Therapeutics 10/2022